Tag Archives: New York

RESI New York Innovation Challenge – Finalists Announced

2 Nov

By Cole Bunn, Senior Research Analyst, LSN

cole-wpWe are excited to showcase the top 36 innovation challenge startups from the first ever RESI conference to be held in New York City. These handpicked companies represent the key sectors of the healthcare space including therapeutics, medical devices, diagnostics and healthcare IT and were selected based on their scientific/technical merit and commercial viability.

The Innovation Challenge companies will compete for each attendee’s RESI Cash tokens throughout the day, which serves as a vote of their potential. The top 3 companies will win additional RESI tickets to events of their choosing, giving them access to hundreds of additional investors and ultimately enhancing their likelihood of securing an investment. Make sure to visit the exhibition hall to meet the RESI innovators and “invest” in your favorites!

Therapeutic

Medical Device

Healthcare IT

Diagnostic

Tags: , , , ,

RESI New York City: Venture Philanthropy Panel Announcement

2 Nov

By Christine A. Wu, Senior Research Analyst, LSN

chrsitine

Venture philanthropic foundations have deep expertise that is often overlooked. Each foundation has a specific, genuine mission towards a disease area that provides them enormous capacity to bring forward more than any entrepreneur can realize. Along with funding, venture philanthropic investors can provide patient access for underserved populations, specialize in assessing and tracking “positively impactful” technology in their particular field, and utilize their own relationships with traditional ventures in creative ways, among other initiatives.

New York City is home to a great number of life science foundations. LSN has dedicated the Venture Philanthropy panel to the following five incredible Foundations for the RESI New York City Conference on November 15th. Moderated by John Walter, CEO and President of Alliance for Cancer Gene Therapy, the audience will have an exclusive opportunity to hear from:

  • Alyssa Reimer, Associate Director, Research Partnerships, The Michael J. Fox Foundation for Parkinson’s Research
  • Michael Batten, Director, Strategic Partnerships, Juvenile Diabetes Research Foundation (JDRF) T1D Fund
  • Ken LaMontagne, VP of Research, Therapy Acceleration Program, Leukemia & Lymphoma Society
  • Andres Hurtado-Lorenzo, Director of Translational Research, Crohn’s and Colitis Foundation

Venture philanthropy investors maintain the genuine purpose of moving forward in the field of life science. Non-traditional investors such as these groups are great funding sources with incredible knowledge in their fields, while also taking inspirational strides to achieve their goals.

Foundations are a strong reminder not to lose track of the mission in life science.

Register before it’s too late to hear first-hand from this fantastic panel!

Tags: , , , ,